Zurück zu Projekte

15807.1;9 PFLS-LS

Development of transducible artificial transcription factor therapeutics (TAFTs): A new generation of drugs for ophthalmic disorders.

Zusammenfassung

Development of transducible artificial transcription factor therapeutics (TAFTs): A new generation of drugs for ophthalmic disorders.

Weitere Texte

Abstract

The proposed CTI project aims to develop TAFTs for the treatment of ophthalmic diseases such as retinal vascular diseases, glaucoma and age-related macula degeneration. TAFTs are a new class of biologics modulating gene expression. They are designed to target expression of specific receptor proteins connected to the pathophysiology of eye diseases. The project is expected to bring TAFTs from the preclinical to the clinical stage, thus strenghening Aliophtha's TAFT pipeline.

Beteiligte

Albert Neutzner

Kontaktperson

albert.neutzner@unibas.ch

University of Basel Albert Neutzner Hebelstrasse 20 4031 Basel BS CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2013-09-30
Enddatum
2015-06-30
Bewilligte Gesamtkosten
CHF 819287.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • T490 Biotechnology 100.0%